Important Deadlines for Cassava Sciences Shareholders in Class Action Lawsuit Revealed
Cassava Sciences Class Action Lawsuit Alert
In an important reminder for investors, ClaimsFiler has announced that shareholders who purchased stocks of Cassava Sciences, Inc. (Nasdaq: SAVA) during the designated class period, specifically between February 7, 2024, and November 24, 2024, have until February 10, 2025, to file lead plaintiff applications in an ongoing class action lawsuit. This lawsuit is currently pending in the United States District Court for the Western District of Texas.
Key Details of the Case
This class action stems from allegations that Cassava Sciences and several of its executives may have failed to disclose critical information during the specified class period, thus violating federal securities laws. On November 25, 2024, the company made a significant disclosure regarding the topline results of its first Phase 3 study on its leading drug candidate, simufilam, specifically the
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.